Global Cardiac Surgical Robots Markets Report 2015-2021: Market Shares, Strategies, and Forecasts for the $2.2 Billion Industry

Dec 16, 2015, 04:10 ET from Research and Markets

DUBLIN, Dec. 16, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/h9qrjt/cardiac_surgical) has announced the addition of Wintergreen Research, Inc's new report "Cardiac Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide, 2015-2021" to their offering.

The automated process revolution in surgery and communications is being implemented via robots. Robots automation of systems is providing significant improvement in the accuracy of surgery and the repeatability of process.

Intuitive Surgical owns the market as the major participant with compelling market share in cardiac and lung surgical robots. This leadership position will need to be defended as other vendor products, now in clinical trials come to market. Advanced technology, an installed base and a well trained core group of surgeons give Intuitive Surgical market advantage.

The market penetration of the cardiac and lung surgical robots will go to 100 percent in the US top hospitals within five years. As the surgeons migrate to the places that have the robotic surgical equipment, other hospitals and their potential patient populations notice. If the hospital does not have the surgical robotic equipment, it will not have any surgeons, this is a bad situation for a hospital. The cardiac and lung robotic surgical equipment permits better surgery and the surgeons and patients know this.

The cardiac and lung surgical robot market is characterized enormous variety and innovation. A surgical robot recurring revenue business model is essentially a large one time purchase for a system complimented by replaceable or disposable instruments that cumulatively make the market a much larger and sustainable ongoing market. Vendors make money from the one time sale of a system and recurring revenue from sale of devices used in every operation.

Initially, a vendor sells and installs the surgical system into new customer accounts. Once systems are sold into customer accounts, the vendor generates recurring revenue as customers use the system to perform surgery. To do cardiac and lung robotic surgeries, the customers need to buy and consume instruments and accessory products. Vendors also generate recurring revenue from system service.

The aging US population has supported demand, since the occurrence of health issues that require medical devices is higher in the elderly population. Buoyed by strong demand and sales, industry profit margins have increased considerably during the past five years.

Hospitals are adopting robotic surgical devices to improve their outcomes numbers. Hospitals are measured on outcomes, robots for surgery, when used by a trained physician are improving outcomes significantly. Hundreds of universities worldwide have research programs in robotics and many are awarding degrees in robotics. These roboticists are increasingly being hired by Global 2000 organizations to link mobile robots (mobile computers) into existing IT systems.

Robot-assisted surgery gives the surgeon better control over the surgical instruments and a better view of the surgical site. Surgeons no longer have to stand throughout the surgery and do not tire as quickly. Hand tremors are filtered out by the robot's computer software. The surgical robot can continuously be used by rotating surgery teams. 3D viewing of the surgical site on a large screen improves visualization of the surgical operating field.

Key Topics Covered:

1. Cardiac Surgical Robot Market Description and Market Dynamics

2. Heart and Lung Surgical Robot Market Shares and Market Forecasts

3. Cardiac Surgical Robots Product Descriptions

4. Cardiac Surgical Robots Technology and Research

5. Cardiac and Lung Surgical Robots Company Descriptions

Companies Mentioned

- Chinese Surgical Robots - Corindus - Freehand - Intuitive Surgical - Johnson and Johnson / DePuy Synthes - Medrobotics - Medtronic - Meerecompany / Eterne - Titan Medical - TransEnterix

For more information visit http://www.researchandmarkets.com/research/h9qrjt/cardiac_surgical

Source: Wintergreen Research, Inc

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com